High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
CONCLUSIONS: <br />The 14-day high dose PPI- bismuth-containing quadruple therapy with probiotic can provide an excellent cure rate for<br />H. pylori infection as first line treatment irrespective of CYP2C19 and antibiotic resistance pattern. Adding probiotic<br />also significantly reduced treatment-related adverse events and improve the patients' compliance.
PMID: 31554388 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Biaxin | Cancer | Cancer & Oncology | Clarithromycin | Gastric (Stomach) Cancer | Gastritis | Gastroenterology | Helicobacter Pylori | Metronidazole | Peptic Ulcer | Probiotics | Study | Thailand Health